Paid Clinical Trials Plainfield
Discover 2,198 paid clinical trials in Plainfield, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
ABP 234 vs. KeytrudaA Study to Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer
Sponsor:
Amgen
Location:
Code:
NCT06311721
Conditions
Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
ABP 234
Pembrolizumab (US)
Pembrolizumab (EU)
RibociclibRoll-over Study to Allow Continued Access to Ribociclib
Sponsor:
Novartis Pharmaceuticals
Location:
Code:
NCT05161195
Conditions
Metastatic Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Ribociclib
Letrozole
Anastrozole
Goserelin
Tamoxifen
TTFields & PembrolizumabLUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Sponsor:
NovoCure GmbH
Location:
Code:
NCT06216301
Conditions
Metastatic Non-small Cell Lung Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
NovoTTF-200T
Pembrolizumab
Platinum based chemotherapy
Immunotherapy with SurgeryComparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Sponsor:
SWOG Cancer Research Network
Location:
Code:
NCT04510597
Conditions
Metastatic Clear Cell Renal Cell Carcinoma
Metastatic Renal Cell Carcinoma
Stage IV Renal Cell Cancer AJCC v8
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Cytoreductive Nephrectomy
Active Comparator
BiomarkersUsing Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial
Sponsor:
ECOG-ACRIN Cancer Research Group
Location:
Code:
NCT04462406
Conditions
Advanced Melanoma
Clinical Stage III Cutaneous Melanoma AJCC v8
Clinical Stage IV Cutaneous Melanoma AJCC v8
Melanoma of Unknown Primary
Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Ipilimumab
Nivolumab
Patient Observation
Pembrolizumab
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Radiation Therapy with AtezolizumabTesting the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT04402788
Conditions
Extensive Stage Lung Small Cell Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Atezolizumab
Biospecimen Collection
Computed Tomography
Magnetic Resonance Imaging
Positron Emission Tomography
Immunotherapy & ChemotherapyMeasuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT06422806
Conditions
Metastatic Undifferentiated Pleomorphic Sarcoma
Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
Unresectable Undifferentiated Pleomorphic Sarcoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Biospecimen Collection
Diagnostic Imaging Testing
Doxorubicin
Echocardiography Test
Multigated Acquisition Scan
Surgical ProceduresA Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Sponsor:
NRG Oncology
Location:
Code:
NCT04251052
Conditions
Ovarian Carcinoma
Eligibility Criteria
Sex: Female
Age: 35 - 50
Healthy Volunteers: Not accepted
Interventions
Bilateral Salpingectomy
Bilateral Salpingectomy with Oophorectomy
Biospecimen Collection
Quality-of-Life Assessment
Questionnaire Administration
Venetoclax & ObinutuzumabTesting Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT04269902
Conditions
Chronic Lymphocytic Leukemia
Small Lymphocytic Lymphoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Biospecimen Collection
Bone Marrow Aspiration
Bone Marrow Biopsy
Computed Tomography
Obinutuzumab
Olaparib & BevacizumabTesting Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Sponsor:
NRG Oncology
Location:
Code:
NCT06580314
Conditions
Fallopian Tube Endometrioid Adenocarcinoma
Fallopian Tube High Grade Serous Adenocarcinoma
FIGO Stage III Ovarian Cancer 2014
FIGO Stage IV Ovarian Cancer 2014
Ovarian Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Bevacizumab
Biospecimen Collection
Computed Tomography
Magnetic Resonance Imaging
Olaparib